Letter in response to the article "optimum timing of blood tests for monitoring patients with clostridium difficileyassociated diarrhea" (J investig med.2010;58[4]:621-624)

Journal of Investigative Medicine

Volumn 58, Issue 6, 2010, Pages 807-

  Pant, Chaitanya ^a   Sferra, Thomas J ^a   Bass, Pat F ^a   Burton, Gary V ^a   Minocha, Anil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

BLOOD ANALYSIS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; LETTER; LEUKEMIA; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPHOMA; MORTALITY; PATIENT MONITORING; PREDICTOR VARIABLE;

CLOSTRIDIUM;

EID: 77957986775     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3181e61a79     Document Type: Letter

References (2)

1. Bhangu A, Czapran A, Bhangu S, et al. Optimum timing of blood tests for monitoring patients with Clostridium difficile-associated diarrhea. J Investig Med. 2010;58(4):621-624.
2. Hardt C, Berns T, Treder W, et al. Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J Gastroenterol. 2008;14(27):4338-4341.